Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

La Jolla Labs Inc. is a therapeutics company specializing in the design and discovery of RNA-targeting therapeutics, leveraging modern RNA biology, machine learning, and automation to develop…

La Jolla Labs Inc. is a therapeutics company specializing in the design and discovery of RNA-targeting therapeutics, leveraging modern RNA biology, machine learning, and automation to develop…
Focus: RNA-targeting therapeutics and discovery tools
Platform: Machine learning, automation, HTS, and RNA splicing software (LJSplice)
Founded: 2020
Headcount (reported): 10
Notable funding: $8.5M seed (Jan 2022) — investor listed: NFX
Leadership: Tamar Grossman, Ph.D. named CEO (Feb 1, 2025); Jeff Milton moved to CTO
Design and discovery of RNA-targeting medicines (antisense oligonucleotides, siRNA, miRNA) and enabling software/tools to accelerate RNA therapeutic programs.
2020
Biotechnology
$8.5M
Seed entry listed in January 2022
“NFX listed as investor for Seed round”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week